Alivus Life Sciences Limited (ALIVUS) reported revenue of ₹640 Cr and net profit of ₹160 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
The statements below are read from Alivus Life Sciences Limited’s filed results, 25 filed quarters and 9 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Jul 31, 2026 · audited
| ₹ Cr | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026Latest | YoYlatest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 397 | 521 | 500 | 467 | 525 | 562 | 522 | 514 | 490 | 509 | 541 | 621 | 578 | 595 | 573 | 537 | 589 | 507 | 642 | 650 | 602 | 588 | 673 | 689 | 640 | +6.4% |
| 290 | 424 | 375 | 327 | 394 | 411 | 386 | 382 | 343 | 366 | 395 | 415 | 385 | 428 | 400 | 395 | 430 | 373 | 452 | 451 | 430 | 409 | 442 | 475 | 429 | -0.2% | |
| Operating profit | — | — | — | — | — | — | — | — | 147 | 144 | 145 | 206 | 193 | 167 | 173 | 142 | 159 | 134 | 190 | 198 | 172 | 179 | 231 | 215 | 212 | +22.9% |
| OPM % | — | — | — | — | — | — | — | — | 30.0% | 28.2% | 26.9% | 33.2% | 33.4% | 28.1% | 30.1% | 26.4% | 27.0% | 26.4% | 29.7% | 30.5% | 28.6% | 30.5% | 34.4% | 31.1% | 33.1% | +4.4 pp |
| Other income | 1.73 | 0.01 | 0.37 | 0.34 | 3.99 | 2.09 | 3.53 | 5.10 | 9.49 | 10.0 | 6.61 | 2.84 | 1.85 | 5.37 | 1.69 | 3.13 | 5.49 | 8.53 | 10.5 | 10.1 | 8.99 | 14.7 | 13.9 | 22.8 | 22.4 | +149.3% |
| Interest | — | — | — | — | — | — | — | — | 0.14 | 0.13 | 0.16 | 0.12 | 0.40 | 0.40 | 0.39 | 0.00 | 0.00 | 0.00 | 0.46 | 1.26 | 1.25 | 1.32 | 1.49 | 1.31 | 1.31 | +4.5% |
| Depreciation | — | — | — | — | — | — | — | — | 9.88 | 9.94 | 10.8 | 11.5 | 12.6 | 13.1 | 13.2 | 15.0 | 14.0 | 15.0 | 15.2 | 16.0 | 17.1 | 18.4 | 19.7 | 20.2 | 20.6 | +20.6% |
| Profit before tax | 108 | 96.7 | 125 | 141 | 135 | 153 | 140 | 138 | 146 | 144 | 141 | 198 | 182 | 159 | 161 | 130 | 150 | 127 | 185 | 191 | 163 | 174 | 198 | 216 | 212 | +30.2% |
| Tax % | 25.3% | 25.0% | 25.4% | 25.6% | 25.2% | 24.5% | 25.8% | 28.1% | 25.7% | 25.6% | 25.6% | 25.9% | 25.6% | 25.3% | 26.1% | 24.5% | 25.8% | 25.2% | 26.0% | 25.8% | 25.4% | 25.3% | 24.3% | 24.6% | 24.6% | -0.9 pp |
| Net profit | 81.1 | 72.5 | 93.4 | 105 | 101 | 115 | 104 | 98.9 | 109 | 107 | 105 | 146 | 135 | 119 | 119 | 97.9 | 111 | 95.3 | 137 | 142 | 122 | 130 | 150 | 163 | 160 | +31.7% |
| EPS (₹) | — | — | — | — | — | — | — | — | 8.87 | 8.72 | 8.57 | — | 11.05 | 9.69 | 9.69 | — | — | — | 11.18 | 11.57 | 9.91 | 10.60 | 12.25 | 13.23 | 13.04 | +31.6% |
